believe that interconnections between human toxicology and the environment are vital and suggest that joint efforts could further benefit these two mutually related fields. The lack of standardized methods and materials consideration and incomplete statistics needs to be worked out to progress in this context. Addressing these issues will widen the scope for nanomaterials' reasonable use for nanobiotechnology-based pharmaceutical design to combat infection, neurological problems, and drug delivery .